With swine flu fears on the rise, companies in the business of sterilization have seen an influx of investors.
Johnson & Johnson (JNJ), Cantel Medical (CMN) and Steris (STE) are a few names I came across while reading a recent Barron’s article. According to the article, shares of Steris have risen 54 percent since early March and from the article’s title (”Shares of Sterilization Equipment Maker Steris Will Keep Rising”) they are expected to keep climbing.
With a rise like that, and such a bold title, I had to explore.
After reading the article and digging into the stock, a couple of things threw me off.
52-week performance - In the …read more

In an attempt to further their development of flu vaccines and antibodies, Johnson & Johnson has partnered with Crucell. The partnership, which involves Johnson & Johnson subsidiary Ortho-McNeil-Janssen Pharmaceuticals, will also work to fight other types of diseases but will immediately focus on prevention and treatment of the flu.
Paul Stoffels of Johnson & Johnson recently talked about how a universal vaccine for flu strains would be a huge help in the health care industry.
Said Stoffels: “A universal antibody or vaccine that protects against a broad range of strains would be an important advance in helping doctors and nurses manage the …read more

Here is a great Jobcast Podcast. Take a moment and listen to the podcast if you are a job seeker. Johnson & Johnson is a great organization to consider as you look for the next opportunity.